SCHEMBL23569353

SCHEMBL23569353

COC(=O)CCSc1cc(F)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR1 P25024 1/20 0.40
CXCR2 P25025 1/20 0.40
PTGS1 P23219 1/20 0.39
MAPK14 Q16539 1/20 0.37
KAT2B Q92831 4/20 0.35
KMT2A Q03164 3/20 0.35
TSHR P16473 2/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
GSTP1 P09211 1/20 0.34
GSTM2 P28161 1/20 0.34
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23568846 0.79 PTGS1 (0.39) CXCR1CXCR2PTGS1MAPK14KAT2B
SCHEMBL9627350 0.74 PTGS1 (0.40) CXCR1CXCR2PTGS1KAT2BKMT2A
SCHEMBL23569352 0.69 SMN1; SMN2 (0.39) KAT2BKMT2AALDH1A1LMNAMAPT
SCHEMBL10594957 0.68 PTGS1 (0.40) CXCR1CXCR2PTGS1KMT2ATSHR
SCHEMBL11732818 0.67 MAPT (0.45) KMT2ATSHRALDH1A1LMNAMAPT
SCHEMBL970491 0.67 PTGS1 (0.39) CXCR1CXCR2PTGS1KMT2ATSHR
SCHEMBL22303067 0.66 MAPT (0.39) CXCR1CXCR2PTGS1KAT2BALDH1A1
SCHEMBL16724105 0.66 SMN1; SMN2 (0.41) CXCR1CXCR2PTGS1KMT2ATSHR
SCHEMBL16200678 0.66 PKM (0.39) CXCR1CXCR2PTGS1KMT2ATSHR
SCHEMBL12471098 0.66 RAB9A (0.57) CXCR1CXCR2MAPK14KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021123237-A1 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE Oxford Drug Design Limited (GB) 2021-06-24 WO disclosed